We have identified a new point mutation in the myelin protein zero (P0) gen
e in two genetically identical twins with a demyelinating neuropathy. The G
to A transition at nucleotide position 382 caused an aspartic acid to aspa
ragine substitution in exon 3. Moreover, we found clear clinical difference
s which were most evident at an early age. These observations suggest that
the expression of this P0 mutation may be susceptible to external, non-gene
tic influences that may act early in the course of the disease to alter the
phenotype.